Auger-Messier M - Search Results

1

C-Terminal modifications of apelin-13 significantly change ligand binding, receptor signaling, and hypotensive action.

Murza A, Besserer-Offroy É, Côté J, Bérubé P, Longpré JM, Dumaine R, Lesur O, Auger-Messier M, Leduc R, Sarret P, Marsault É. Murza A, et al. J Med Chem. 2015 Mar 12;58(5):2431-40. doi: 10.1021/jm501916k. Epub 2015 Feb 24. J Med Chem. 2015. PMID: 25668242

2

Molecular cloning of a ferret angiotensin II AT(1) receptor reveals the importance of position 163 for Losartan binding.

Gosselin MJ, Leclerc PC, Auger-Messier M, Guillemette G, Escher E, Leduc R. Gosselin MJ, et al. Biochim Biophys Acta. 2000 Jun 2;1497(1):94-102. doi: 10.1016/s0167-4889(00)00046-x. Biochim Biophys Acta. 2000. PMID: 10838163 Free article.

3

A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling.

Leclerc PC, Auger-Messier M, Lanctot PM, Escher E, Leduc R, Guillemette G. Leclerc PC, et al. Endocrinology. 2002 Dec;143(12):4702-10. doi: 10.1210/en.2002-220679. Endocrinology. 2002. PMID: 12446598

4

Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor.

Pérodin J, Deraët M, Auger-Messier M, Boucard AA, Rihakova L, Beaulieu ME, Lavigne P, Parent JL, Guillemette G, Leduc R, Escher E. Pérodin J, et al. Biochemistry. 2002 Dec 3;41(48):14348-56. doi: 10.1021/bi0258602. Biochemistry. 2002. PMID: 12450401

5

Methionine proximity assay, a novel method for exploring peptide ligand-receptor interaction.

Rihakova L, Deraët M, Auger-Messier M, Pérodin J, Boucard AA, Guillemette G, Leduc R, Lavigne P, Escher E. Rihakova L, et al. J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):297-313. doi: 10.1081/rrs-120014603. J Recept Signal Transduct Res. 2002. PMID: 12503623

6

The constitutively active N111G-AT1 receptor for angiotensin II maintains a high affinity conformation despite being uncoupled from its cognate G protein Gq/11alpha.

Auger-Messier M, Clement M, Lanctot PM, Leclerc PC, Leduc R, Escher E, Guillemette G. Auger-Messier M, et al. Endocrinology. 2003 Dec;144(12):5277-84. doi: 10.1210/en.2003-0677. Epub 2003 Aug 13. Endocrinology. 2003. PMID: 12960024

7

Down-regulation of inositol 1,4,5-trisphosphate receptor in cells stably expressing the constitutively active angiotensin II N111G-AT(1) receptor.

Auger-Messier M, Arguin G, Chaloux B, Leduc R, Escher E, Guillemette G. Auger-Messier M, et al. Mol Endocrinol. 2004 Dec;18(12):2967-80. doi: 10.1210/me.2003-0488. Epub 2004 Aug 26. Mol Endocrinol. 2004. PMID: 15331757

8

Importance of N-glycosylation positioning for cell-surface expression, targeting, affinity and quality control of the human AT1 receptor.

Lanctot PM, Leclerc PC, Clément M, Auger-Messier M, Escher E, Leduc R, Guillemette G. Lanctot PM, et al. Biochem J. 2005 Aug 15;390(Pt 1):367-76. doi: 10.1042/BJ20050189. Biochem J. 2005. PMID: 15869468 Free PMC article.

9

The constitutively active N111G-AT1 receptor for angiotensin II modifies the morphology and cytoskeletal organization of HEK-293 cells.

Auger-Messier M, Turgeon ES, Leduc R, Escher E, Guillemette G. Auger-Messier M, et al. Exp Cell Res. 2005 Aug 1;308(1):188-95. doi: 10.1016/j.yexcr.2005.04.015. Exp Cell Res. 2005. PMID: 15896777

10

S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II.

Leclerc PC, Lanctot PM, Auger-Messier M, Escher E, Leduc R, Guillemette G. Leclerc PC, et al. Br J Pharmacol. 2006 Jun;148(3):306-13. doi: 10.1038/sj.bjp.0706725. Br J Pharmacol. 2006. PMID: 16565729 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters